Call Us: 1.800.873.5297

By

Compounding Pharmacy Recalls Anti-Inflammatory Drug in 13 States

Main Street Family Pharmacy LLC has announced a voluntary recall of one of its pharmaceutical products.  The product, an injectable anti-inflammatory drug, has been linked to seven cases of adverse events in the form of skin abscesses, one of which, the FDA reports, appears to be fungal in nature.  Although the investigation into the exact source […]

By

Class I Recall of GranuFlo® and Naturalyte® Dialysis Medications

GranuFlo®, along with Naturalyte®, is a component of dialysis solution used in cleaning a patient’s blood during dialysis treatment.  The drug has been linked to a number of harmful side effects and injuries, including stroke, cardiac arrhythmia, and cardiac arrest.  Such dangers led to a Class I Recall of the drug in 2012. As the […]

By

SSRI Side Effect May Include Surgical Complications

According to a recent report, research suggests that Zoloft®, a commonly prescribed selective serotonin reuptake inhibitor (SSRI), may lead to surgical complications.  A study conducted by Dr. Andrew Auerbach and his team revealed that patients taking Zoloft® and other SSRIs were more likely to be readmitted to the hospital within a month of surgery.  The […]

By

New Research Points to Potentially Fatal Risks of Pradaxa® Bleeding Complications

This month, two new studies evaluate the dangers of intracranial Pradaxa® brain hemorrhage among patients with closed head injuries. In the Journal of Neurosurgery report, researchers compared case studies among head trauma patients on Warfarin®, an older blood thinner, with patients on Pradaxa® and others who took no anticoagulants. The study included fifteen patients who […]

By

Doctor Substantiates Bladder Cancer Link at First Actos® Trial in California

According to a report about the first Actos® lawsuit to go to trial in California, Dr. Norm Smith, a professor at the University of Chicago Medical Center, testified about the medical effects of Jack Cooper’s ingestion of Actos®. In particular, the doctor noted that Mr. Cooper had a history of cigarette smoking, including a bout […]

By

Court Documents Reveal 40 Percent Hip Failure Rate for DePuy ASR™ System

According to California court documents released in April, an internal evaluation by Johnson & Johnson found that nearly 40 percent of patients with a DePuy ASR™ (Articular Surface Replacement) hip system would experience total failure within five years. Most prosthetic hips, however, are engineered to last up to fifteen years, with hip replacement rates after […]

By

GranuFlo® Lawsuits Consolidated in Massachusetts Federal Court

On March 29, 2013, the Judicial Panel on Multidistrict Litigation (JPML) announced that all NaturaLyte® and GranuFlo® federal lawsuits will be consolidated for pre-trial proceedings in the Northern District of Massachusetts. Fresenius Medical Care, the manufacturer of NaturaLyte® and GranuFlo®, began selling the dialysates in 2003, when they first received FDA approval. Both are engineered […]

By

Pradaxa® Multi District Litigation

According to a news update, Boehringer Ingelheim, the manufacturer of the anticoagulant Pradaxa®, is the target of a lawsuit over allegations that the drug leads to severe internal bleeding.  One of the plaintiffs in this lawsuit – which is now part of the Pradaxa® MDL pending in the Southern District of Illinois – Robert Connelly, […]

By

Consumers’ Union Urges FDA to Require Safety Testing of Metal on Metal Hips and Other High Risk Implants

On April 13, 2013, the Consumers’ Union sent a letter to the FDA urging it to adopt a rule that would require the agency’s premarket approval (PMA) to review high risk implants in order to determine their safety.  According to the letter, which was signed by more than 11,000 people, current loopholes in the law […]

By

Status of Actos® Litigation Pending in Cook County, Illinois

There are currently over 2,000 Actos bladder cancer claims on file against Takeda Pharmaceuticals in Cook County Circuit Court in Chicago, Illinois. As of now, the first trials for the Cook County consolidated litigation are scheduled to commence in Chicago within the next year. Actos® is a medication prescribed to control glucose (blood sugar) in […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.